Manajemen Psikofarmakologi Untuk Kesehatan Mental
DOI:
https://doi.org/10.30587/psikosains.v21i1.9388Keywords:
management, psychology, psychopharmacologyAbstract
Background: Treatment of mental illness with pharmacotherapy is closely monitored in clinical centers. While in most developed countries, this practice is well established.. Objective: The purpose of this study was to analyze and investigate the handling of mentally ill patients at the Mental Health Center. Method: This research methodology uses simple quantitative methods to identify and evaluate prescription quantity and distribution. Result: Of the described drug therapies, while disorders were categorized according to the International Classification of Diseases-10R. According to the clinic, there were no significant changes in the route of drug administration (p > 0.11). Almost, two-thirds of the prescribed drugs were essential (66.1%). Considering the therapeutic drug classes, more than half were antipsychotics (53.2%), while the percentages of 17.2% and 13.8% were anticholinergic drugs and anxiolytics/hypnotics. These drug classes were 84.2% of the total drugs used Conclusion: Conclusions on the use of effective drugs with low safety such as clozapine. The implementation of drug prescribing practices needs to be considered by stakeholders, for future strategies in the selection and provision of psychopharmacology.
Downloads
References
Alidema, F., Isjanovski, V., Hasani, A., Hailaj, B. V., & Beqiraq, M. A. (2022). Pharmacotherapy of mental illness in the mental health centers in kosovo during 2021. Journal Scientific SPIROSKI, 1249-1256. doi.org/10.3889/oamjms.2022.10395
Awad, A. G. (2024). Drug Therapy in Schizophrenia Variability of Outcome and Prediction of Response. The Canadian Journal, 1-10.
Bruins, J., Pijnenborg, M., & Jorg, F. (2020). Cannabis use in people with severe mental illness: The association with physical and mental health – a cohort study. A Pharmacotherapy Monitoring and Outcome Survey study. Journal of Psychopharmacology, 1-10.
Gilman, G. (2022). The Pharmacological Basis of Therapeutics. California: McGraw-Hill Medical Publishing.
Grossman, A., Prata, N., Jones, S., Laser, L., & Ganatra, B. (2023). A descriptive summary of the WHO availability assessments of medical abortion medicines in eight African countries. Reproductive Health Journal, 195-210.
Jhon, S. (2022). The World Health Report 2021: New Understanding, New Hope. PubMed Central Journal, 20-28.
Kapczinsinki, F., Amaral, O. B., Madruga, M., & Quevedo, J. (2021). Use and misuse of benzodiazepines in Brazil: A review. SUBSTANCE USE & MISUSE Journal, 1053-1069.
Kumar, N., Adhikari, T., Singh, J. K., Tiwari, N., & Acharya, A. S. (2021). Health data from diaries used in low-income communities. Europe PMC Journal, 446-454.
Lovdahl, U., & Riska, E. (2020). The Construction of Gender and Mental Health in Nordic Psychotropic-Drug Advertising. Sage Journals, 387-406.
Marazuela, R., Terres, C. R., Giner, J., & Jimenez, F. J. (2020). Pharmacoeconomic analysis of the treatment of schizophrenia with quetiapine, olanzapine, risperidone or haloperidol in Spain. Journal of Medical Economics, 1-20.
Meraya, A. K., Alwhabi, M., & Syeed, M. H. (2020). Utilization of Psychotropic Medications and Polypharmacy Among Adults. Indonesian Journal of Pharmacy, 1-12.
Pikalov, A. (2022). The Value of Referring to Recently Introduced Antipsychotics. American Journal of Psychiatry, 1531-1552.
Sirunyan, J. (2020). Observation of long-range, near-side angular correlations in proton-proton collisions at the LHC. Jornal of High Energy Physics, 1-18.
Walker, R., & Edwards, C. (2023). Clinical Pharmacy and Therapeutics. Journal Pharmacy and Pharmacology, 1709-1719.
Zito, J. M., & Safer, D. J. (2020). Child and Adolescent Psychiatry and Mental Health. Journal BioMed, 1-9.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 PUPUT MULYONO

This work is licensed under a Creative Commons Attribution 4.0 International License.

